Shiota Junya, Zaki Nureen H Mohamad, Merchant Juanita L, Samuelson Linda C, Razumilava Nataliya
Departments of Internal Medicine, The University of Michigan.
Departments of Internal Medicine, The University of Michigan; Molecular & Integrative Physiology, The University of Michigan.
J Vis Exp. 2019 Apr 23(146). doi: 10.3791/59544.
Cholangiopathies, which affect extrahepatic bile ducts (EHBDs), include biliary atresia, primary sclerosing cholangitis, and cholangiocarcinoma. They have no effective therapeutic options. Tools to study EHBD are very limited. Our purpose was to develop an organ-specific, versatile, adult stem cell-derived, preclinical cholangiocyte model that can be easily generated from wild type and genetically engineered mice. Thus, we report on the novel technique of developing an EHBD organoid (EHBDO) culture system from adult mouse EHBDs. The model is cost-efficient, able to be readily analyzed, and has multiple downstream applications. Specifically, we describe the methodology of mouse EHBD isolation and single cell dissociation, organoid culture initiation, propagation, and long-term maintenance and storage. This manuscript also describes EHBDO processing for immunohistochemistry, fluorescent microscopy, and mRNA abundance quantitation by real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR). This protocol has significant advantages in addition to producing EHBD-specific organoids. The use of a conditioned medium from L-WRN cells significantly reduces the cost of this model. The use of mouse EHBDs provides almost unlimited tissue for culture generation, unlike human tissue. Generated mouse EHBDOs contain a pure population of epithelial cells with markers of endodermal progenitor and differentiated biliary cells. Cultured organoids maintain homogenous morphology through multiple passages and can be recovered after a long-term storage period in liquid nitrogen. The model allows for the study of biliary progenitor cell proliferation, can be manipulated pharmacologically, and may be generated from genetically engineered mice. Future studies are needed to optimize culture conditions in order to increase plating efficiency, evaluate functional cell maturity, and direct cell differentiation. Development of co-culture models and a more biologically neutral extracellular matrix are also desirable.
影响肝外胆管(EHBDs)的胆管病包括胆道闭锁、原发性硬化性胆管炎和胆管癌。它们没有有效的治疗选择。研究EHBD的工具非常有限。我们的目的是开发一种器官特异性、通用的、成体干细胞衍生的临床前胆管细胞模型,该模型可以很容易地从小鼠野生型和基因工程小鼠中生成。因此,我们报告了一种从成年小鼠EHBDs开发EHBD类器官(EHBDO)培养系统的新技术。该模型具有成本效益,易于分析,并且有多种下游应用。具体来说,我们描述了小鼠EHBD分离和单细胞解离、类器官培养起始、增殖、长期维持和储存的方法。本手稿还描述了用于免疫组织化学、荧光显微镜检查以及通过实时定量逆转录聚合酶链反应(qRT-PCR)进行mRNA丰度定量的EHBDO处理方法。该方案除了能产生EHBD特异性类器官外,还有显著优势。使用来自L-WRN细胞的条件培养基显著降低了该模型的成本。与人类组织不同,使用小鼠EHBDs为培养物生成提供了几乎无限的组织。生成的小鼠EHBDO包含一群纯的上皮细胞,具有内胚层祖细胞和分化胆管细胞的标志物。培养的类器官在多次传代后保持均匀的形态,并且在液氮中长期储存后可以恢复。该模型允许研究胆管祖细胞增殖,可以进行药物处理,并且可以从小鼠基因工程小鼠中生成。未来需要进行研究以优化培养条件,以提高接种效率、评估功能性细胞成熟度并指导细胞分化。共培养模型和更具生物学中性的细胞外基质的开发也是可取的。